Biosynth Offers Novel Human Hybrid IgM Monoclonal Antibodies to Replace Natural Disease State Plasma
Dublin, Ireland, 31st August 2023 – Biosynth Ltd, is delighted to offer the following innovative range of novel Human Hybrid IgM...
Event snippet :